Treatment in Regions of Interest

Metastatic cancer is not one disease, but many diseases with different responses to therapy, and treatment resistance in even a small fraction of disease can correlate to poor overall clinical outcome. Clinical teams need to be able to identify and target the resistant tumours among dozens or even hundreds of tumours. However, manual assessment of all lesions is not practical, reliable or economically viable.

TRAQinform IQ quantifies change over time during the course of treatment for each individual region of interest. It is designed to work with images already captured without any modifications and produces a change report to the clinical team as part of normal clinical workflow.

FDA approved features:

Automated matching of Regions of Interest (ROI) between previously performed CT and PET/CT DICOM 3.0 volumetric medical images
In order to perform automated matching of ROI and quantitative analysis of previously performed CT and PET/CT DICOM 3.0 volumetric medical images, the software initially performs the following functions:
- Machine learning skeletal and anatomic structure segmentation
- Threshold-based ROI identification and contouring
- Automated quantitative analysis to assess previously performed CT and PET/CT DICOM 3.0 volumetric medical images, including: change in total volume and density of each identified ROI, and change in tracer uptake of each identified ROI among images
Generation of images of the anatomy combined with spatial and quantitative information, including computed classification of quantitative changes in ROI

TRAQinform IQ system features for the Australia market, support various medical imaging functions, including:

Identifying Regions of Interest (ROIs) and performing ROI contouring, which allows for quantitative and statistical analysis of full or partial body scans
Evaluating ROIs by measuring functional burden, response, and heterogeneity, as well as providing 3D interactive rendering of images with highlighted ROIs

Automatic Organ Segmentation.
Earlier Determination and Prediction of Treatment Toxicity.
Automated Lesion Detection and Quantitative Response Assessment of Diagnostic CT Images.
Comprehensive – AIQ’s technology doesn’t provide a single parameter, but a complimentary set of quantitative and special biomarkers that provide the critical information to enable clinical decision support.
Clinical decision support - Reports tailored to each patient provides detailed information informing clinical decision for therapy optimization.
Patient centric - Correlating individual patient (not population) assessments to outcomes facilitates personalised medical care.

TRAQinform IQ

Overview

Features

Modalities

Subspecialities

Benefits

Image examples

Book a meeting